loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

America: Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development - Arsenalbio

Post Enquiry
POST ENQUIRY